Crossmark

Preoperative chemoradiotherapy with capecitabine and triweekly oxaliplatin versus capecitabine monotherapy for locally advanced rectal cancer: a propensity-score matched study

Crossref DOI link: https://doi.org/10.1186/s12885-022-09855-z

Published Online: 2022-07-18

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Li, Anchuan

Huang, Tingxuan

Zheng, Rong

Chi, Pan

Li, Zhihua

Wang, Xiaozhong

Xu, Benhua
License Information

Text and Data Mining valid from 2022-07-18

Version of Record valid from 2022-07-18
More Information

Article History

Received: 12 December 2021

Accepted: 4 July 2022

First Online: 18 July 2022

Declarations

:

: Not applicable.

: The retrospective study was approved by the Clinical Research Ethics Committee of the Fujian Medical University Union Hospital. Due to the retrospective nature of the study, the Clinical Research Ethics Committee of the Fujian Medical University Union Hospital waived the informed consent.

: The authors have no relevant financial or non-financial interests to disclose.

Document is current

Any future updates will be listed below